Studies breast milk and infant gut bacteria in Malaysia and China
Follows mothers and infants to see how breast milk bacteria relate to infant health.
Plain-language title generated from the registry record
Registry title: Mother-Infant Cohort Study in Malaysia and China
Key facts
- Where
- Kajang, MalaysiaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for pregnant women aged 18 to 45 who are less than 12 weeks pregnant and plan to attend check-ups for a year after the birth. The study follows mother and baby for 2 years and gives no treatment.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Pregnant, less than 12 weeks along (gestational age)
Main reasons for not taking part
- Diagnosed with immune deficiency
- Multiple pregnancy (for example twins) or preterm delivery (before 37 weeks)
- Plans to move out of the study area in the next year
- Baby with a birth defect (congenital abnormality)
This trial only enrols pregnant participants. The registry sentence this rests on: Pregnant women aged between 18 and 45 years old
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT04919265, who can take part
Where in Malaysia
- Private hospitalKajang, MalaysiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universiti Putra Malaysia
- Trial code
- NCT04919265
- Record updated
- 13 December 2024
- Original description
This mother-infant cohort study aims to determine the geographic differences in the microbial profiles in breast milk from mothers living in Malaysia and China that are potentially important determinants of infant development. It also aims to determine the impact of gut microbiome on infant health (temperament, gastrointestinal symptoms, eczema symptoms, and asthma symptoms).Read full original descriptionShow less
Breastmilk, Infant Gut Microbiome and the Impact on Infant Health: a Prospective Mother-Infant Cohort Study in Malaysia and China
This mother-infant cohort study aims to determine the geographic differences in the microbial profiles in breast milk from mothers living in Malaysia and China that are potentially important determinants of infant development. It also aims to determine the impact of gut microbiome on infant health (temperament, gastrointestinal symptoms, eczema symptoms, and asthma symptoms).
Inclusion: Pregnant women aged between 18 and 45 years old; Pregnant women who attend the antenatal check-up at the selected clinics/hospitals; Pregnant women with the gestational age of less than 12 weeks; Pregnant women who plan to attend post-natal check-ups for at least one year at the same clinic/hospital.
Exclusion: Pregnant women who are diagnosed with immune deficiency; Pregnant women who have a multiple pregnancy and preterm delivery (<37 weeks); Pregnant women who plan to move out of the study area in the next one year; Pregnant women with fetal/newborn with congenital abnormalities.